Benazzo, A., Cho, A., Nechay, A., Schwarz, S., Frommlet, F., Wekerle, T., . . . Jaksch, P. (2021). Combined low-dose everolimus and low-dose tacrolimus after Alemtuzumab induction therapy: A randomized prospective trial in lung transplantation. Trials, 22(1), 1. https://doi.org/10.1186/s13063-020-04843-9
Chicago Style (17th ed.) CitationBenazzo, Alberto, Ara Cho, Anna Nechay, Stefan Schwarz, Florian Frommlet, Thomas Wekerle, Konrad Hoetzenecker, and Peter Jaksch. "Combined Low-dose Everolimus and Low-dose Tacrolimus After Alemtuzumab Induction Therapy: A Randomized Prospective Trial in Lung Transplantation." Trials 22, no. 1 (2021): 1. https://doi.org/10.1186/s13063-020-04843-9.
MLA (9th ed.) CitationBenazzo, Alberto, et al. "Combined Low-dose Everolimus and Low-dose Tacrolimus After Alemtuzumab Induction Therapy: A Randomized Prospective Trial in Lung Transplantation." Trials, vol. 22, no. 1, 2021, p. 1, https://doi.org/10.1186/s13063-020-04843-9.